Outcome of dyslipidemic covid 19 patients in intensive care unit submitted to hemodialysis

Background and Aims: Hyperlipidemia by itself without the concurrence of other major risk factors for cardiovascular disease, for it aggregates more inflammation to the process and thus leading higher probable cytokine storm. In rare cases of COVID 19 patients without these factors the outcome is better but the literature is scarce on the topic. The aim of this work is to look at the prevalence of outcomes in these patients with only hyperlipidemia and in cases in which only one risk factor is associated. Methods: From January to December 2020, 758 COVID 19 patients admitted to the intensive care unit at a hospital in Sao Paulo and 315 had indication of hemodyalisis. COVID 19 patients were classified as to Dyslipidemia, Hypertension and Diabetes and sequentially reclassified as Hyperlipidemia (DLP) alone, DLP plus Hypertension and DLP plus Diabetes. Results: As of October the outcome of these patients were discharged was in May 2020 and December, respectively, for DLP of 2 and 20%;DLP plus Diabetes of 15 and 7%;DLP and Hypertension of 15 and 7% was 3.7% and in December the second wave brought it up to 8.3%. Association with Hypertension was in 230 cases. Diabetes coincided with lipid abnormalities in 169 cases. Outcome was better when only one factor coincided with only one more risk factor. Conclusions: COVID 19 patients in ICU have better outcomes when submitted to Hemodialysis if the number of patients with only Diabetes or Hypertension be present risk factors associated to lipid disorders are less.